Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
US$2.21
FV
50.2% undervalued intrinsic discount119.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
New narrative
US$500.00
FV
3.4% overvalued intrinsic discount6.75%
Revenue growth p.a.
6users have liked this narrative
1users have commented on this narrative
15users have followed this narrative
7 days ago author updated this narrative
US$234.75
FV
1.4% undervalued intrinsic discount13.60%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
New narrative
€4.02
FV
52.2% undervalued intrinsic discount8.50%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Updated narrative
AL
Community Contributor
Great Stock, overvalued
Palantir has a lot of potential but the current valuation already prices this in (and more). P/E Ratio: Current P/E ratio of 237.8 isn't sustainable.
View narrativeUS$13.25
FV
1.2k% overvalued intrinsic discount16.79%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
10 months ago author updated this narrative
PK
Community Contributor
Biotech longerterm bet
211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.
View narrativeCHF 33.10
FV
14.0% undervalued intrinsic discount11.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 1 year ago author updated this narrative
US$48.70
FV
8.9% undervalued intrinsic discount3.00%
Revenue growth p.a.
0users have liked this narrative
1users have commented on this narrative
2users have followed this narrative
30 days ago author updated this narrative
JU
Community Contributor
BWA VALUATION
Catalysts Are there any products or services that could move sales or earnings meaningfully? yes Are there any industry tailwinds this stock is benefitting or hindered from?
View narrativeUS$39.17
FV
6.5% overvalued intrinsic discount6.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
about 1 year ago author updated this narrative
CA$47.40
FV
246.7% overvalued intrinsic discount2.50%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
7 months ago author updated this narrative
US$25.41
FV
51.2% undervalued intrinsic discount48.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
6 months ago author updated this narrative
zł204.19
FV
6.8% overvalued intrinsic discount8.49%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
10 months ago author updated this narrative
US$82.68
FV
61.6% undervalued intrinsic discount12.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
6 months ago author updated this narrative
US$2.18
FV
50.5% undervalued intrinsic discount38.51%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
24 days ago author updated this narrative